blog

Rob Laurens Discusses Navigating Patient Travel During COVID-19 with Outsourcing-Pharma

By Elizabeth Gargill on Wed, Aug 19, 2020 | 3 min read

 

Earlier this week, Principal of RSG Services Rob Laurens went one-on-one with Outsourcing-Pharma to discuss challenges associated with patient travel as COVID-19 restrictions ease.

In this in-depth interview, Rob addresses the importance of contingency planning, lessons learned, and the long-term impact of COVID-19 on patient travel. He also provides insight into services and resources that clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond. Click here to read the full article.

Topics: Patient Travel, Patient Travel Programs, RSG Arrive, COVID-19, Rob Laurens, RSG Services, Outsourcing-Pharma

Managing Patient Travel as Countries and Study Sites Reopen

By Elizabeth Gargill on Wed, Jul 29, 2020 | 2 min read

The Road to Reopening

In our newest Pharma15 Live! episode, Principal of RSG Services Rob Laurens provides guidance on managing clinical trial patient travel as COVID-19 restrictions ease and countries and study sites start to reopen.

Rob answers common questions and highlights the advantages of thoughtful pre-planning and contingency preparation. Watch now and discover strategies clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond.

 

Download the eBook

Download eBook

 

Because there's a lot to consider in terms of managing patient travel as COVID-19 restrictions ease, we've captured guidance in a special eBook to download and review at your convenience.

 

Topics: Patient Engagement, Patient Travel, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Rob Laurens

What and When to Submit to the IRB?

By Elizabeth Gargill on Wed, Apr 29, 2020 | 1 min read

Insights from Advarra on Managing Changes to Patient Enrollment & Engagement due to COVID-19

Get an IRB's perspective on managing clinical trial enrollment modifications due to COVID-19 by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra.

Topics: Patient Engagement, Pharma15 Live!, COVID-19, Clinical Trial Enrollment, Institutional Review Board, Rob Laurens, IRB

 
Subscribe To Our Blog